Shares of Invivo Therapeutics Holdings Corp. (OTC: NVIV), a development-stage company engaged in the development and commercialization biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral, nerve injuries, and other neurotrauma conditions, are climbing in trading today. At last check, NVIV shares were trading 3.48% higher at $3.27 on above average volume of [...]
Recent Comments